Finance

Lists
002294:SHE
Shenzhen Salubris Pharmaceuticals Co Ltd
CN¥ 30.85
+1.38%
(+0.42) 1D
10-р сарын 15, 11:40:15 (GMT+8)  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002294...
Open
CN¥ 30.02
High
CN¥ 31.50
Low
CN¥ 29.91
Mkt. cap
33.85 тэрбум
Avg. vol.
9.32 сая
Volume
12.27 сая
Dividend
1.78%
Quarterly dividend
CN¥ 0.14
Ex-dividend date
2026 оны 5-р сарын 26
P/E ratio
51.06
52-wk high
CN¥ 70.99
52-wk low
CN¥ 29.25
EPS
CN¥ 0.60
Shares outstanding
1.11 тэрбум
No. of employees
4 мян
Open
CN¥ 30.02
High
CN¥ 31.50
Low
CN¥ 29.91
Mkt. cap
33.85 тэрбум
Avg. vol.
9.32 сая
Volume
12.27 сая
Dividend
1.78%
Quarterly dividend
CN¥ 0.14
Ex-dividend date
2026 оны 5-р сарын 26
P/E ratio
51.06
52-wk high
CN¥ 70.99
52-wk low
CN¥ 29.25
EPS
CN¥ 0.60
Shares outstanding
1.11 тэрбум
No. of employees
4 мян
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
1 цагийн өмнө
FILE PHOTO: SK Hynix at the Nasdaq market in New York
Simply Wall Street
Simply Wall Street
·
30 минутын өмнө
Raised Guidance Could Change The Case For Nextpower Stock
Profile
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company. Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019. Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
About Shenzhen Salubris Pharmaceuticals Co Ltd
CEO-
Employees4.09 мян
Founded1998 оны 11-р сарын 3
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
1.11 тэрбум
1.11 тэрбум
1.23 тэрбум
1.25 тэрбум
Cost of goods sold
279.29 сая
302.88 сая
287.67 сая
343.20 сая
Cost of revenue
279.29 сая
302.88 сая
287.67 сая
343.20 сая
Research and development expenses
127.63 сая
176.44 сая
131.32 сая
139.63 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
486.77 сая
568.30 сая
551.61 сая
596.71 сая
Operating expense
595.66 сая
770.11 сая
694.36 сая
749.18 сая
Total operating expenses
874.96 сая
1.07 тэрбум
982.03 сая
1.09 тэрбум
Operating income
235.37 сая
38.38 сая
246.41 сая
158.32 сая
Other non operating income
-14.62 сая
13.83 сая
-5.27 сая
5.40 сая
EBT including unusual items
234.09 сая
5.21 сая
255.47 сая
142.37 сая
EBT excluding unusual items
246.15 сая
72.00 сая
252.02 сая
160.96 сая
Income tax expense
18.06 сая
-56.18 сая
29.65 сая
-22.28 сая
Effective tax rate
7.72%
-1,078.48%
11.60%
-15.65%
Other operating expenses
-17.83 сая
34.11 сая
9.61 сая
16.33 сая
Net income
215.63 сая
70.80 сая
225.27 сая
161.82 сая
Net profit margin
19.42%
6.37%
18.34%
12.94%
Earnings per share
-
-
-
-
Interest and investment income
26.87 сая
37.76 сая
15.05 сая
12.29 сая
Interest expense
-4.88 сая
-7.50 сая
-4.17 сая
-4.97 сая
Net interest expenses
22.00 сая
30.27 сая
10.88 сая
7.32 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
325.52 сая
135.48 сая
343.52 сая
257.90 сая
Gain or loss from assets sale
-983.77 мян
3.03 сая
-
166.24 мян
AI content may include mistakes. Learn more
Google аппс